Gilda Trandafirescu
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Metabolism, Diabetes, and Cancer, Diabetes Treatment and Management, Genetic Associations and Epidemiology, Diabetes Management and Research
Most-Cited Works
- → Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study(2019)124 cited
- → Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial(2025)2 cited
- → A phase 2/3 randomized study of BMS-986504 with nab-paclitaxel (nab-P) and gemcitabine (GEM) in first-line (1L) metastatic pancreatic ductal adenocarcinoma (PDAC) with homozygous MTAP deletion ( MTAP -del): MountainTAP-30.(2026)